Background: The number of patients with ESRD is increasing and the gap between the demand for KT and available donors is widening. Thus deceased donation is very important to the donor pool for ESRD.
Introduction
Kidney transplantation (KT) is the preferred treatment for end stage renal disease (ESRD). A successful transplant triples the life expectancy of a renal failure patient. The projected life expectancy with a transplant was 17.19 years compared with only 5.84 years on dialysis [1] . Hence, despite an initial higher risk of death, long-term survival for patients who underwent transplantation is significantly better compared with patients who remain on dialysis.
In addition, KT is more cost effective and improves quality of life. A study showed that the costs of patient therapy by hemodialysis are far greater than transplantation and its maintenance by almost three and a half times [2] . In a study [3] , composed of 50 kidney transplant patients and 100 hemodialysis patients which measured the quality of life using the validated McGill Questionnaire consisting of a part A (total life quality: physical, emotional, social, spiritual and financial) and 16 questions divided in 5 different spheres (physical symptoms, physical well-being, psychological symptoms, existential well-being and support) showed a statistically significant difference in quality of life between dialysis and transplant patients wherein the quality of life of kidney transplant patients is 18.12% greater. Another study showed that KT provides greater survival benefits to patients with end-stage renal disease, at less cost.
There is an increasing prevalence of ESRD and the demand for KT is increasing. Majority comprise living donation and unfortunately decease donation has not increase at an equivalent rate to meet the demand for KT [4] . In the Philippines, there are 10,000-12,000 new cases of ESRD annually [5] . In which 50% to 60% will need KT but only 10% is done. Of those being transplanted, 90% were from living donors and only 10% from deceased organ donation.
Various studies were done in the Philippines regarding outcome of deceased donor KT as shown in Table 1 [6] [7] [8] . These studies showed a remarkable improvement in the outcome of deceased donor KT. 
Materials and Methods
The following data were reviewed and collected from medical records and Philippine Renal Disease Registry (PRDR): a) recipients' demographic characteristics such as age, gender, cause of kidney disease, presence of diabetes mellitus, immunosuppressive regimen, induction therapy and immunologic status (Panel reactive antibody (PRA), number of HLA-ABDR mismatches and HLA-DR mismatches); b) donor factors such as age, gender and cold ischemia time (CIT). Patients were followed up to 7 years post-KT to determine graft and patient survival.
Definition of terms
• Patient survival is the survival from the date of transplant until the date of death.
• Graft survival is the presence of renal function adequate to prevent the patient from resuming maintenance dialysis.
•
Graft loss is patient's permanent return to dialysis.
Statistical analysis
The demographic profile of recipients and donors were expressed as frequency count, percentage and mean with standard deviation. Kaplan Meier was used to determine graft and patient's survival rate.
To establish correlation between certain factors and survival, logistic regression analysis was utilized.
Ethical consideration
Confidentiality of the subjects was maintained. Anonymity was ensured and each patient was assigned a case number. performed at the National Kidney and Transplant Institute, 1,488 (93.1%) were from living donors and 110 (6.9%) were from deceased donors. Among the 110 recipients of deceased grafts, 91 (82.7%) patients were included in this study and 19 (17.3%) patients were excluded due to the following reasons: 3were foreigners; 10 pediatric patients and 6 had incomplete data.
Demographic characteristics
The mean recipient age was 40.40 ± 11.8 years and 65.9% were males. The primary renal diseases were chronic glomerulonephritis (63.7%), diabetic nephropathy (18.7%) and hypertensive nephrosclerosis (6.6%). There were 39.6% of patients who had 3 HLA mismatches and 61.5% with at least 1 DR match. Majority received induction therapy (90.1%) and 64.8% had tacrolimus-based immunosuppressive regimen (Table 2) .
Graft and patient outcome
The survival rate at 1, 3, 5 and 7 years for patients was 91, 89, 86 and 86 percent while graft survival was 89, 79, 73 and 68 percent respectively (Figures 1 and 2) . The leading cause of death was Infection (76%) followed by cardiovascular disease (14%). Most of the death occurred less than 5 years post-KT (Table 3 ).
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Factors associated with graft and patient survival at 7 years post-kidney transplant
Among the recipient factors studied, none were found to be significantly associated with graft and patient survival at 7 years post-KT (Tables 4 and 5 ).
Among the donor factors studied, cold ischemia time was significantly associated with patient survival rate among the listed and specified factors while the gender of the donor was significantly associated with graft survival rate.
Patient Survival Rate among patients was significantly different when grouped according to cold ischemia time. (Log Rank=6.81, p=0.033). Cold ischemia time with less than 12 had highest estimated mean survival rate (6.83 years), followed by 12-24 CIT (6.46 years). Patients with cold ischemia time greater than 24 had the lowest estimated survival rate (5.52 years) ( male donors had significantly higher estimated survival rate (6.06 years) than patients with female donors (3.69 years) ( Table 7) .
Discussion
There has been continuous improvement in graft and patient survival from 1983 to 2010 [6] [7] [8] .
Our study showed an improvement in graft survival when compared to studies done from 1983 to 2001 probably due to the improved immunosuppressive regimen, used of induction therapy and shorter cold ischemia time. When compared with the United States Renal Data System (USRDS) of 2013, our study was comparable in which their 1 st , 3 rd and 5 th year patient survival rate were 94%, 86.6% and 75.5% while graft survival rates were 91.8%, 82.6% and 70.5% respectively [9] .
The most common cause of death in our study was infection (76.9%) followed by cardiovascular disease (15.4%). Compared with the United States Renal Data System (USRDS) data the most common cause of death was cardiovascular disease (31%), infectious (19%) and malignancies (10%) [9] . However in a study in India of 160 deceased donor KT during 2006-2009, the most common cause of death was infection which was comparable to our study [10] . Factors for the high incidence of infections were unhygienic conditions, late presentation and diagnosis, high cost of life-saving antimicrobial agents and lack of sensitive and specific diagnostic tools that were either not available or were too expensive [10, 11] .
Among the recipient and donor factors studied, the donor's gender was noted to affect the 7-year graft survival in which male donor had better outcome than female (p value=0.001). This was similar to the study involving 464 renal transplant centers in Europe in which both patient and graft survival were worse with a female donor. Graft survival in female recipients of male donors was 48.4 ± 0.4 year vs. 46.9 ± 0.6 year for female donors (p value=0.0020). In male recipients, actuarial survival was 46.5 ± 0.3 year for male donor's vs. 42.1 ± 0.5 year for female donors (p value<0.0001). The assumption about the relative benefit of a male donor is that male kidneys have greater nephron number [12] .
Another known risk factor that reduced long term survival of deceased KT was cold ischemia time. Patients with CIT of 12 h had a significant patient survival. This is explained because there was less rejection with shorter CIT hence no need to give solumedrol pulsing hence no infection which is the main cause of patient mortality. The acute rejection with prolonged ischemia time could be reversed with solumedrol pulsing but could cause severe infection which may lead to death. United Network for Organ Sharing (UNOS) data noted a reduction in CIT during the 10-year period (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) with an overall reduction of 4.8 h and noted improvement in 3-year graft survival (80% in 1996-2000 vs. 72% in 1990-1995; p<0.001) [13] . Another study showed that CIT had a significant effect on the 6-year graft survival, a 10-hour increase in CIT was associated with a hazard risk ratio (HRR) of 1.20 for graft failure (p<0.001) [14] . In our study, CIT <12 h showed better 7-year graft survival compared to CIT 12 h to 24 h and >24 h however it did not achieved statistical significance. In contrast, CIT influence on patient survival achieved statistical significance (P value=0.033). CIT with less than 12 h had highest estimated mean survival rate (6.83 years), followed by 12 h to 24 h CIT (6.46 years) and >24 h CIT had the lowest estimated survival rate (5.52 years).
Conclusion
The survival rate at 1 st , 3 rd , 5 th and 7 th years for kidney transplant patients in the Philippines was 91%, 89%, 86% and 86% while graft survival was 89%, 79%, 73% and 68% respectively which is comparable to international data like UNOS. The most common cause of death was infection followed by cardiovascular disease. Among the recipient and donor factors, the donor's gender had effect on the 7-year graft survival in which male deceased donor KT had better graft survival compared to females and cold ischemia time was significantly associated with patient survival rate with CIT of less than 12 h having better survival compared to CIT 12 h to 24 h and >24 h.
